Guardian Pharmacy Services, Inc. (GRDN) is a Medical - Distribution company in the Healthcare sector, currently trading at $37.79. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of GRDN = $60.97 (+61.3% from the current price, the stock appears undervalued). Analyst consensus target is GRDN = $36 (-4.7% upside).
Valuation: GRDN trades at a trailing Price-to-Earnings (P/E) of 51.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 4.82.
Financials: revenue is $1.4B, +16.8%/yr average growth. Net income is $49M, growing at -113.8%/yr. Net profit margin is 3.4% (thin). Gross margin is 19.5% (-0.9 pp trend).
Balance sheet: total debt is $45M against $206M equity (Debt-to-Equity (D/E) ratio 0.22, conservative). Current ratio is 1.38 (adequate). Debt-to-assets is 10.8%. Total assets: $413M.
Analyst outlook: 3 / 3 analysts rate GRDN as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 21/100 (Fail), Growth 48/100 (Partial), Past 75/100 (Partial), Health 83/100 (Pass), Moat 42/100 (Fail), Future 74/100 (Pass), Income 30/100 (Fail).
